Islet Transplantation at the University of Alberta: Status Update and Review of Progress over the Last Decade

Canadian Journal of Diabetes

Volumn 36, Issue 1, 2012, Pages 32-37

  Senior, Peter A ^a,b   Kin, Tatsuya ^a   Shapiro, James ^a,b   Koh, Angela ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hypoglycemia; Immunosuppression; Islet transplant; Type 1 diabetes

Indexed keywords

RAPAMYCIN; TACROLIMUS;

ARTICLE; CLINICAL EFFECTIVENESS; CYTOPENIA; DIABETIC MICROANGIOPATHY; DIARRHEA; DISEASE SEVERITY; DRUG WITHDRAWAL; EDEMA; FATIGUE; FATTY LIVER; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MENORRHAGIA; MENSTRUATION DISORDER; MOUTH ULCER; OPPORTUNISTIC INFECTION; OVARY CYST; PANCREAS ISLET TRANSPLANTATION; PATIENT SELECTION; PERIPHERAL EDEMA; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT CONTRAINDICATION;

EID: 84864303342     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2012.01.002     Document Type: Article

References (42)

1. Shapiro A.M., Lakey J.R., Ryan E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
2. Khan M.H., Harlan D.M. Counterpoint: clinical islet transplantation: not ready for prime time. Diabetes Care 2009, 32:1570-1574.
3. Cravedi P., Mannon R.B., Ruggenenti P., et al. Islet transplantation: need for a time-out?. Nature clinical practice Nephrology 2008, 4:660-661.
4. Robertson R.P. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004, 350:694-705.
5. Bromberg J.S., LeRoith D. Diabetes cure-is the glass half full?. N Engl J Med 2006, 355:1372-1374.
6. Couzin J. Diabetes. Islet transplants face test of time. Science 2004, 306:34-37.
7. Ryan E.A., Paty B.W., Senior P.A., et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005, 54:2060-2069.
8. Grady D. Diabetes treatment disappoints in new study. The New York Times: Sep. 27, 2006. Accessed February 6, 2012. http://www.nytimes.com/2006/09/27/health/27cnd-diabetes.html.
9. Williams P. Notes on diabetes treated with extract and by grafts of sheep's pancreass. BMJ 1894, 2:1303-1304.
10. Scharp D.W., Lacy P.E., Santiago J.V., et al. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation 1991, 51:76-85.
11. Brendl M, Hering B, Schulz A, Bretzel A. International islet transplant registry report. Giessen: University of Giessen:1999.
12. Owen R., Ryan E., O'Kelly K., et al. Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology 2003, 229:165-170.
13. Moberg L., Johansson H., Lukinius A., et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002, 360:2039-2045.
14. Walsh T., Eggleston J., Cameron J. Portal hypertension, hepatic infarction, and liver failure complicating pancreatic islet autotransplantation. Surgery 1982, 91:485-487.
15. Ryan E., Lakey J., Paty B., et al. Successful islet transplantation: Continued insulin reserve provides long-term glycemic Control. Diabetes 2002, 51:2148.
16. Engels E.A., Pfeiffer R.M., Fraumeni J.F., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011, 306:1891-1901.
17. Hopwood P., Crawford D.H. The role of EBV in post-transplant malignancies: a review. J Clin Path 2000, 53:248.
18. Ryan E.A., Lakey J.R., Rajotte R.V., et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001, 50:710-719.
19. Bhargava R., Senior P.A., Ackerman T.E., et al. Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004, 53:1311-1317.
20. Alfadhli E., Koh A., Albaker W., et al. High prevalence of ovarian cysts in premenopausal women receiving sirolimus and tacrolimus after clinical islet transplantation. Transpl Int 2009, 22:622-625.
21. Senior P.A., Paty B.W., Cockfield S.M., et al. Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant 2005, 5:2318-2323.
22. Letavernier E., Legendre C. mToR inhibitors-induced proteinuria: mechanisms, significance, and management. Transpl Rev 2008, 22:125-130.
23. Senior P.A., Zeman M., Paty B.W., et al. Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant 2007, 7:91-98.
24. Bellin M.D., Kandaswamy R., Parkey J., et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant 2008, 8:2463-2470.
25. 2009 Scientific Summary of the Collaborative Islet Transplant Registry (CITR). Rockville, MD: 2009. Accessed February 6, 2012. http://www.citregistry.org/.
26. Toso C., Shapiro A.M.J., Bowker S., et al. Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation 2007, 84:664-666.
27. Hering B., Kandaswamy R., Ansite J., et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005, 293:830-835.
28. Koh A., Imes S., Ryan E., et al. Improved tolerability of tacrolimus plus mycophenolate mofetil without graft compromise in islet transplantation. Diabetes 2008, 57(Suppl 1):1952.
29. Villiger P., Ryan E.A., Owen R., et al. Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant 2005, 5:2992-2998.
30. Kawahara T., Kin T., Kashkoush S., et al. Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation. Am J Transplant 2011, 11:2700-2707.
31. Koh A., Senior P., Salam A., et al. Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation 2010, 89:465-471.
32. Koh A., Imes S., Kin T., et al. Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. Transplantation 2010, 89:361-365.
33. Thompson D.M., Meloche M., Ao Z., et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 2011, 91:373-378.
34. Koh A., Rudnisky C., Tennant M., et al. Positive effects of clinical islet transplantation on diabetic retinopathy over 5 years. Diabetes 2011, 60(Suppl 1):A205.
35. Albaker W., Koh A., Ryan E., et al. Diabetic peripheral neuropathy is stabilized after clinical islet transplantation 7 year follow-up study. J Clin Endocrinol Metab 2008, 93(Suppl 1). OR26-2.
36. Kennedy W., Navarro X., Goetz F., et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990, 322:1031-1037.
37. Fung M.A., Warnock G.L., Ao Z., et al. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: An interim report. Transplantation 2007, 84:17-22.
38. Rickels M, Barton FB, Alejandro R, et al. Factors of islet transplant success: Results from the Collaborative Islet Transplant Registry 1999-2010. In: 13th World Congress of International Pancreas and Islet Transplant Association. Prague: 2011.
39. Shapiro AJ, Toso C, Imes S, et al. Five-year results of islet-alone transplantation match pancreas-alone transplantation with alemtuzumab, Tac/MMF, with strong suppression of auto and alloreactivity. In: 13th World Congress of International Pancreas and Islet Transplant Association. Prague: 2011.
40. Gala-Lopez B.L., Senior P.A., Koh A., et al. Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation. Am J Transplant 2011, 11:2708-2714.
41. Shapiro A.M.J., Ricordi C., Hering B.J., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006, 355:1318-1330.
42. Shapiro A., Ricordi C., Hering B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 2003, 362:1242.